PFKM and central nervous system cancer: A PFK1 isoform with reduced sensitivity to citrate inhibition (Ki = 0.75 mM citrate) and increased sensitivity to activation by F2,6P was described in human glioma cells (as compared to the enzyme from normal brain tissue (Ki = 0.1 mM citrate); [32].